Armata Pharmaceuticals, Inc.ARMPNYSE
Loading
R&D Expenses Over TimeContracting
Percentile Rank80
3Y CAGR-9.3%
5Y CAGR+12.6%
Year-over-Year Change
Research and development spending
3Y CAGR
-9.3%/yr
vs +63.6%/yr prior
5Y CAGR
+12.6%/yr
Recent deceleration
Acceleration
-72.9pp
Decelerating
Percentile
P80
Within normal range
vs 5Y Ago
1.8x
Solid growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $26.10M | -24.2% |
| 2024 | $34.43M | +1.9% |
| 2023 | $33.77M | -3.6% |
| 2022 | $35.02M | +75.0% |
| 2021 | $20.02M | +38.6% |
| 2020 | $14.44M | +47.0% |
| 2019 | $9.82M | +100.8% |
| 2018 | $4.89M | +69.8% |
| 2017 | $2.88M | -49.3% |
| 2016 | $5.68M | - |